These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 31212828

  • 21. Shedding Light on the Role of Na,K-ATPase as a Phosphatase during Matrix-Vesicle-Mediated Mineralization.
    Sebinelli HG, Andrilli LHS, Favarin BZ, Cruz MAE, Bolean M, Fiore M, Chieffo C, Magne D, Magrini A, Ramos AP, Millán JL, Mebarek S, Buchet R, Bottini M, Ciancaglini P.
    Int J Mol Sci; 2022 Dec 01; 23(23):. PubMed ID: 36499456
    [Abstract] [Full Text] [Related]

  • 22. Opposing effects of tyrosine kinase inhibitors on mineralization of normal and tumor bone cells.
    Klein BY, Tepper SH, Gal I, Shlomai Z, Ben-Bassat H.
    J Cell Biochem; 1997 Jun 01; 65(3):420-9. PubMed ID: 9138097
    [Abstract] [Full Text] [Related]

  • 23. RhoA/ROCK pathway inhibition by fasudil suppresses the vasculogenic mimicry of U2OS osteosarcoma cells in vitro.
    Xia Y, Cai X, Fan J, Zhang L, Li Z, Ren J, Wu G, Zhu F.
    Anticancer Drugs; 2017 Jun 01; 28(5):514-521. PubMed ID: 28225457
    [Abstract] [Full Text] [Related]

  • 24. Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces the osteoblastic differentiation of the human osteosarcoma cell line SaOS-2.
    Postiglione L, Domenico GD, Montagnani S, Spigna GD, Salzano S, Castaldo C, Ramaglia L, Sbordone L, Rossi G.
    Calcif Tissue Int; 2003 Jan 01; 72(1):85-97. PubMed ID: 12232677
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Tenascin C affects mineralization of SaOS2 osteoblast-like cells through matrix vesicles.
    Li C, Cui Y, Luan J, Zhou X, Li H, Wang H, Shi L, Han J.
    Drug Discov Ther; 2016 Jan 01; 10(2):82-7. PubMed ID: 26961327
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Matrix vesicles promote mineralization in a gelatin gel.
    Boskey AL, Boyan BD, Schwartz Z.
    Calcif Tissue Int; 1997 Mar 01; 60(3):309-15. PubMed ID: 9069171
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Rho-kinase regulates extracellular matrix-mediated osteogenic differentiation of periodontal ligament cells.
    Ugawa Y, Yamamoto T, Kawamura M, Yamashiro K, Shimoe M, Tomikawa K, Hongo S, Maeda H, Takashiba S.
    Cell Biol Int; 2017 Jun 01; 41(6):651-658. PubMed ID: 28370928
    [Abstract] [Full Text] [Related]

  • 35. Identification of a novel pyrazolo[3,4-d]pyrimidine able to inhibit cell proliferation of a human osteogenic sarcoma in vitro and in a xenograft model in mice.
    Manetti F, Santucci A, Locatelli GA, Maga G, Spreafico A, Serchi T, Orlandini M, Bernardini G, Caradonna NP, Spallarossa A, Brullo C, Schenone S, Bruno O, Ranise A, Bondavalli F, Hoffmann O, Bologna M, Angelucci A, Botta M.
    J Med Chem; 2007 Nov 15; 50(23):5579-88. PubMed ID: 17929792
    [Abstract] [Full Text] [Related]

  • 36. Fibroblast growth factor-2 inhibits mineralization of osteoblast-like Saos-2 cells by inhibiting the functioning of matrix vesicles.
    Liu C, Cui Y, Luan J, Zhou X, Liu Z, Han J.
    Drug Discov Ther; 2014 Feb 15; 8(1):42-7. PubMed ID: 24647157
    [Abstract] [Full Text] [Related]

  • 37. Pyrazolo pyrimidine-type inhibitors of SRC family tyrosine kinases promote ovarian steroid-induced differentiation of human endometrial stromal cells in vitro.
    Maruyama T, Yamamoto Y, Shimizu A, Masuda H, Sakai N, Sakurai R, Asada H, Yoshimura Y.
    Biol Reprod; 2004 Jan 15; 70(1):214-21. PubMed ID: 14522827
    [Abstract] [Full Text] [Related]

  • 38. Differentially activated Src kinase in chemo-naïve human primary osteosarcoma cells and effects of a Src kinase inhibitor.
    Laschi M, Bernardini G, Geminiani M, Manetti F, Mori M, Spreafico A, Campanacci D, Capanna R, Schenone S, Botta M, Santucci A.
    Biofactors; 2017 Nov 15; 43(6):801-811. PubMed ID: 28786551
    [Abstract] [Full Text] [Related]

  • 39. AnnexinA6: a potential therapeutic target gene for extracellular matrix mineralization.
    Yang J, Pei T, Su G, Duan P, Liu X.
    Front Cell Dev Biol; 2023 Nov 15; 11():1201200. PubMed ID: 37727505
    [Abstract] [Full Text] [Related]

  • 40. Matrix stiffness regulation of integrin-mediated mechanotransduction during osteogenic differentiation of human mesenchymal stem cells.
    Shih YR, Tseng KF, Lai HY, Lin CH, Lee OK.
    J Bone Miner Res; 2011 Apr 15; 26(4):730-8. PubMed ID: 20939067
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.